Tag: Lubrizol

(BRK.A), (BRK.B)

Berkshire Hathaway-owned The Lubrizol Corporation and BASF Corporation have inked a significant licensing agreement for the production and distribution of select EMGARD® and Plurasafe® industrial lubricant products. Effective April 1, 2024, these licensed products will be seamlessly integrated into Lubrizol’s CPI Fluid Engineering brand.

The agreement encompasses a range of BASF products, including EMGARD 2946; EMGARD CL 4046, 4068; EMGARD EP WG 680; EMGARD HT CL 5220, 5320; Plurasafe CL 6032, 6046, 6068; Plurasafe P 44; and Plurasafe WGF 200 E. This collaboration marks a strategic move for both companies to better cater to specific customer requirements in the industrial lubricant market.

Brian Lieberman, Vice President of Fuel and Lubricant Solutions at BASF, expressed confidence in partnering with Lubrizol, citing the company’s expertise and ability to address niche customer needs. Meanwhile, Michael Brubaker, Vice President of Lubrizol Fluid Engineering, emphasized the agreement’s significance in bolstering Lubrizol’s extensive portfolio of Industrial Lubricants, further underscoring the company’s commitment to quality and customer satisfaction.

With Lubrizol boasting over 95 years of experience in researching, developing, and manufacturing specialty high-performance lubricants and BASF’s global presence, the collaboration is poised to deliver enhanced solutions to industrial lubricant customers worldwide.

BASF has taken proactive measures to ensure a smooth transition for affected customers, providing ordering and delivery details for related products. This seamless integration underscores the commitment of both organizations to prioritize customer satisfaction and market leadership in the industrial lubricant sector.

© 2024 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

In a significant stride towards sustainability, Lubrizol Advanced Materials proudly announces that three additional sites within Lubrizol Engineered Polymers have secured the International Sustainability and Carbon Certification (ISCC) PLUS certification. This achievement, obtained at the close of the previous year, underscores Lubrizol’s commitment to environmentally responsible practices.

ISCC PLUS is an esteemed international sustainability certification designed for industrial applications. It sets the standard for fully traceable and sustainable supply chains, enabling companies to monitor and attribute environmentally friendly raw materials throughout the entire value chain. This is accomplished through transparent record-keeping, all without altering the production process.

The three sites that have attained this third-party qualification are Lubrizol Advanced Materials’ headquarters in Brecksville, along with the production plants in Avon Lake, Ohio, U.S., and Oevel, Belgium. This accomplishment follows the ISCC PLUS certification received by Lubrizol’s facility in Songjiang, China, last year. These certifications align with Lubrizol’s dedication to sustainability and the expansion of its ESTANE® TPU sustainable solutions, applicable in various industries such as footwear, electronics, and industrial applications.

Dr. Jesús Santamaria, Global Sustainability Business Director for Lubrizol Engineered Polymers, highlighted the impact of ISCC PLUS on their products, stating, “ISCC PLUS enables a fully transparent biomass balance approach and leads to the decrease of the Product Carbon Footprint (PCF) of our final product. This builds up on the launch of our ESTANE RNW TPU solutions which reduces the PCF with the existing equipment used by our customers, without any change in the production process or final material properties.”

Elizabeth Grove, Chief Sustainable Officer at The Lubrizol Corporation, emphasized the strategic importance of ISCC PLUS certification, stating, “Obtaining ISCC PLUS certification is an important step in ensuring that Lubrizol has a single, consistent, corporate-wide process across our organization to track materials. As we increase our use of bio-based and renewable materials, Lubrizol’s customers are provided even more confidence in our ability to credibly trace these materials through our manufacturing process.”

By adopting the mass balance approach and incorporating the ISCC PLUS external verification system, Lubrizol aims to expand the use of alternative feedstocks. This move supports the acceleration of Lubrizol’s global sustainability journey, demonstrating a commitment to collaborating with partners and building alliances to develop solutions that have positive impacts on the environment and society, outweighing the footprint it takes to produce them.

© 2024 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results

(BRK.A), (BRK.B)

Warren Buffett’s Berkshire Hathaway, known for its strategic acquisitions, has gone the other direction with the sale of Lubrizol Life Science business group Inc. from its portfolio.

The buyer, Agno Pharma, which purchased the company from Berkshire’s The Lubrizol Corporation, is a prominent US-based global pharmaceutical contract development and manufacturing company, is set to leverage this acquisition to enhance its capabilities and services.

The acquisition encompasses the drug product formulation technology associated with Particle Sciences Inc., as well as its development and manufacturing site located in Bethlehem, PA, which employs approximately 65 professionals.

The sale of the unit is a reverse for Lubrizol, which in 2019 had incorporated Particle Science into its Lubrizol Life Science business group. At that time, Lubrizol had also acquired Bavaria Medizin Technologie GmbH, a German contract development and manufacturing organization of intravascular and nonvascular devices.

Particle Sciences, established in 1991, specializes in pre-clinical and clinical stage drug product formulation, offering a comprehensive range of services, including analytic, bioanalytic, physical characterization, and manufacturing. The company excels in handling poorly soluble and highly potent compounds in both sterile and non-sterile environments.

Agno Pharma’s move to acquire Particle Sciences aligns with its strategy to broaden its capacity and capabilities in drug product formulation and clinical manufacturing services on a global scale. The acquisition positions Agno to make significant investments in clinical-scale manufacturing services, expanding from sterile liquid manufacturing and filling to the micronization of sterile powder filling capabilities.

© 2023 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A) (BRK.B)

Berkshire Hathaway’s Lubrizol Corporation, a prominent player in the specialty chemicals and additives industry, has taken a significant step to bolster its presence in the flourishing lubricant and fuel additives market in Bangladesh. The company recently unveiled a strategic distribution agreement with IMCD Group, a globally recognized distributor and formulator of specialty chemicals and ingredients.

Under this new collaboration, IMCD will assume the role of distributing Lubrizol’s cutting-edge technology to an expanding customer base in Bangladesh. This initiative is designed to empower local customers in the formulation of high-performance finished fluids and lubricants, catering to the nation’s growing demand for quality lubricants. It is projected that the finished lubricant market in Bangladesh will experience a Compound Annual Growth Rate (CAGR) of 3-5%.

Lubrizol’s commitment to this endeavor is underscored by Flavio Kliger, Senior Vice President and President of Lubrizol Additives, who stated, “We see tremendous growth potential in South Asia, and that’s why we are investing in the region and committing to fully supporting oil marketers in Bangladesh. This new agreement with IMCD will allow us to reliably service the growing number of additives customers in the country with our high-performance technology.”

The increased need for lubricants and finished fluids in South Asia is being primarily driven by rapid urbanization and industrialization across the region. With growing vehicle fleets and evolving industrial requirements, the demand for high-performance lubricants, fuels, and fluids is on the rise.

Sanjeev Kaul, Vice President of India, Middle East, and Africa for Lubrizol Additives, emphasized the importance of this move, stating, “Bangladesh is an evolving marketplace and requires our dedicated support. Together with IMCD, we are fully equipped to provide that support to a growing customer base.”

This partnership between Lubrizol and IMCD is not their first collaboration. They have previously worked together to distribute additives in various global markets. Their shared successes in India and Africa have played a significant role in expanding their cooperation to Bangladesh.

Narendra Varde, Managing Director of IMCD India & Bangladesh, expressed his enthusiasm, saying, “Lubrizol has been our partner in India for the past four years, and we are now excited to strengthen this relationship by expanding into Bangladesh. With our proven track record of successfully nurturing and expanding businesses in India, bolstered by Lubrizol’s cutting-edge technology and unwavering support from their dedicated team, we are confident in our ability to replicate the success in this region. This collaboration will result in a higher level of service and support for Bangladesh oil marketers looking to distinguish themselves from competitors.”

Flavio Kliger further emphasized their commitment to high-growth markets in the Asia-Pacific region, noting that “Our ongoing relationship with IMCD is proof positive of our investment in high-growth markets, and we’re excited for a mutually successful future.”

Kailash Sawant, Director of Sales for India and South Asia at Lubrizol Additives, underlined the importance of delivering an exceptional customer experience, stating, “We have selected IMCD as our new route to market to cater to Bangladesh customers and enable improved services to every single customer.”

With this strategic partnership, Lubrizol and IMCD are poised to make significant contributions to Bangladesh’s lubricant and fuel additives industry, leveraging their expertise and cutting-edge technology to meet the evolving needs of the market and contribute to the nation’s economic growth.

© 2023 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

In a significant development for the Indian piping industry, Berkshire Hathaway’s Lubrizol, a global leader in specialty chemicals, and Grasim Industries Limited, a flagship company of the Aditya Birla Group, have initiated the construction of the first phase of a massive 100,000 metric-ton CPVC resin plant in Vilayat, Gujarat, India.

This collaborative effort is poised to revolutionize CPVC production in the region, catering to the burgeoning demand for piping applications not only in India but also in neighboring countries such as Nepal, Bangladesh, and Indonesia.

The new CPVC resin plant, situated at Grasim Industries’ complex, is set to become the largest single-site facility for CPVC resin production globally. It is designed to address the escalating need for CPVC materials in India’s construction and plumbing sectors, ensuring a steady supply of high-quality, locally manufactured CPVC resin. The plant will be equipped with Lubrizol’s cutting-edge CPVC resin manufacturing technology and will leverage Grasim’s expertise in reliable manufacturing processes.

In addition to this groundbreaking project, Lubrizol is doubling its existing CPVC compound manufacturing capacity at its Dahej, Gujarat, India site. This expansion will see production capacity soar from 70,000 metric tons to an impressive 140,000 metric tons, solidifying Lubrizol’s position as the largest CPVC producer in the region. It also distinguishes Lubrizol as the sole company with end-to-end CPVC capabilities, enabling its partners to meet the projected 10-12% annual increase in CPVC demand within the Indian market. Furthermore, Lubrizol is planning to establish a research and development center at its Dahej site, catering to the rapidly evolving needs of the Indian market.

The initial phase of the Vilayat resin plant and the expansion at the Dahej facility are scheduled to be operational by early 2025. These projects are anticipated to create over 4,000 direct and indirect job opportunities, contributing significantly to the local economy. In addition, Lubrizol is taking steps to establish a Global Capability Center in India, aimed at supporting regional growth and fostering closer collaboration among employees in the region. Over the next year, Lubrizol plans to hire 150 to 200 new employees at this location, with plans to expand its workforce further in the coming years.

Scott Mold, General Manager of Lubrizol TempRite, expressed his pride in these milestones, emphasizing that Lubrizol’s investment in India is geared toward servicing and supporting the growing demand for CPVC materials, particularly for ensuring access to clean, safe drinking water. India represents a key market for Lubrizol’s global CPVC leadership ambitions.

Lubrizol has been a pioneer in introducing CPVC into the Indian market for the past 25 years, offering a substantial economic development opportunity for the region. Today, India stands as one of the largest consumers of CPVC, primarily for plumbing pipes and fittings, and the increasing demand for clean water in residential and commercial buildings is set to propel continued growth in this sector.

© 2023 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol Corporation has sold its idled Warwick Chemical Mostyn, Wales, UK, site to International Process Plants, a leading global provider of pre-owned and new process plants and equipment.

The Warwick Chemical Mostyn site, which formerly produced stain removal ingredients for detergent products, features a robust infrastructure ideally suited for various chemical applications. IPP plans to sustainably redeploy these assets to its client facilities globally, making the site and its basic infrastructure available for redevelopment to support the local community needs.

The Mostyn site is the second facility that Lubrizol has also sold this month. The company also sold its surfactant plant in Paso Robles, California, to Texas-based Coast Southwest.

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol Corporation, a global leader in specialty chemicals, has sold its surfactant plant in Paso Robles, California, to Texas-based Coast Southwest.

No price of the transaction was announced.

Headquartered in Irving, Texas, Coast Southwest is a leading full-service, chemical distribution and ingredient technology company.

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol Corporation, a global leader in specialty chemicals, is reinforcing its commitment to growth in India with a series of noteworthy projects spanning its portfolio. With an investment exceeding $150 million, Lubrizol is embarking on groundbreaking initiatives that include the construction of India’s largest CPVC resin plant in Vilayat, Gujarat, doubling the capacity of its site in Dahej, Gujarat, establishing a grease lab in Navi Mumbai, and facilitating substantial job growth and innovation within the country.

Lubrizol takes immense pride in announcing its continued dedication to India. Through a multi-year plan, the company will make substantial investments that contribute to clean drinking water, enhanced transportation accessibility, job creation, and sustainable innovation for India’s growing population.

Lubrizol’s involvement in India dates back to 1966 when it began local manufacturing of chemical additives supporting transportation and industrial markets. Over the years, the company’s presence and contributions in India have significantly expanded, offering tailor-made products and solutions for a wide range of industries.

The company’s employee base in India has consistently grown to meet both regional and global requirements. It anticipates generating 4,000 direct and indirect jobs through various new investment ventures:

1. Enabling the World’s Largest CPVC Resin Production with Grasim Industries Limited: Lubrizol introduced CPVC to the Indian market in 2001, presenting a significant economic opportunity for the region. Today, India stands as one of the largest consumers of CPVC, primarily in the form of plumbing pipe and fittings. The growing demand for clean water in residential and commercial buildings is poised to drive further expansion. Lubrizol, in partnership with Grasim Industries Limited, a flagship company of the Aditya Birla Group, will commence the first phase of a state-of-the-art CPVC resin plant with a capacity of 100,000 metric tons in Vilayat. This groundbreaking project will establish the largest single-site CPVC resin production globally, supplying Lubrizol’s renowned brands like FlowGuard® Plus, Corzan®, and BlazeMaster®.

2. Providing Access to Clean Drinking Water by Doubling CPVC Capacity and Establishing R&D Capabilities in Dahej, Gujarat: Lubrizol plans to double its existing CPVC compound capacity at Dahej, Gujarat, from 70,000 to 140,000 metric tons. Additionally, the company intends to establish a local R&D center, marking its second global research facility after North America. With this investment, Lubrizol becomes the sole company in India with end-to-end CPVC capabilities, well-positioned to serve the needs of local Indian customers. The expanded capacity will also cater to neighboring high-growth markets such as Nepal, Bangladesh, and Indonesia.

3. Supporting Transportation and Industrial Customers Worldwide with the Mumbai India Grease Lab and Turbhe Expansion: Lubrizol is firmly committed to supplying high-performance, cost-effective industrial grease-thickening solutions to grease manufacturers globally. Earlier this year, the company unveiled a new grease lab in Navi Mumbai, India, dedicated to testing and developing calcium sulfonate greases with significant potential in the industrial grease market. Since 2020, Lubrizol’s Additives business has introduced over 35 new blends for transportation and industrial applications localized in India. The company has also expanded its production site in Turbhe, incorporating a new storage facility and filtration capabilities.

4. Meeting the Personal Care and Home Care Needs of a Growing Middle Class, with a Focus on Sustainability: As the middle class in India continues to expand, there is an increasing demand for beauty and home care products within the region. As a leading provider of solutions for the beauty and home care industries, Lubrizol is committed to innovative, sustainable solutions that unlock opportunities for its partners in India. For instance, the use of detergent bars for cleaning dishes and laundry is a common practice in India. However, these bars can become soft and ineffective if they remain wet for too long, resulting in inconsistent cleaning and significant waste. To address this, Lubrizol’s Home Care team established a Center of Excellence for laundry bars in Mumbai. This initiative helped a global home care leader achieve its sustainability goals while streamlining processes, earning Lubrizol a sustainability award from the customer earlier this year.

In addition to these significant projects, Lubrizol plans to continue investing in Centers of Excellence capabilities to capitalize on the growth opportunities within the region. These initiatives reflect Lubrizol’s steadfast commitment to India’s development and its unwavering dedication to driving innovation, sustainability, and economic progress.

© 2023 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol Life Science Health (LLS Health) is taking a new, consumer-led approach to its added-value nutraceuticals.

At Vitafoods Europe in Geneva, which takes place from May 9 to 11, 2023, LLS Health will unveil its mission to synchronize supplement makers with their customers’ behaviors. The company’s increased consumer focus will highlight the strengths of its current portfolio of insight-based solutions designed to deliver strong, market-driven product benefits for its customers.

LLS Health has partnered with 113 industries, an AI-driven research company that specializes in developing consumer behavior models using machine learning and AI to gather and analyze vast relevant consumer-generated content. The objective was to gain deeper insights into the purchasing behavior of dietary supplements based on conversations and activities on social media platforms. The research characterized several types of supplement consumers, including health-hooked consumers eager to explore new products to maintain overall well-being, informed seekers of solutions to personal problems, irregular users, mechanical users, skeptics who believe in “food first and supplements only when necessary,” and fertility/pregnancy-minded consumers.

Lubrizol’s goal is to satisfy both the logical, fact-driven, and the emotional, sensory-driven sides of the consumer mind. By investing in new market research and focusing on trending health benefit platforms, Lubrizol brings its customers actionable insights coupled with unique, science-backed branded ingredients while collaborating on supplement innovation. The company’s approach puts consumer needs first, helping manufacturers align with consumer insights and goals.

© 2023 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol Life Science (LLS) – Health, a pharmaceutical company based in Cleveland, Ohio, has been awarded The Medicine Maker 2022 Innovation Award for its revolutionary technology – Apisolex™ Polymer solubilizing excipient.

The Apisolex solubilizing excipient is designed to enhance the solubility of BCS class II and IV APIs by up to 50,000-fold, allowing medications that would have otherwise been discarded to reach the market. The technology is injectable grade and designed to work with simple formulation techniques, streamlining manufacturing and minimizing API loss. It can be mixed with an aqueous-based solution, followed by sterile filtration and lyophilization to form micellar structures that encapsulate the API during lyophilization. The resulting formulation is stable and can be readily resuspended in common diluents for administration, reconstituting in less than 30 seconds in saline.

Apisolex technology stood out from a record number of nominations received, and readers and visitors to The Medicine Maker website voted for their favorite technology. LLS Health emerged as the grand winner.
Joey Glassco, Senior Global Market Manager, Parenterals at LLS Health, expressed her gratitude for the recognition, saying, “We are honored for Apisolex solubilizing excipient to be recognized by readers of The Medicine Maker for this prestigious innovation award. My hope is that winning this award will allow drug formulators struggling with water-insoluble APIs to discover the polymer’s benefits so that more life-changing medications can make it to market.”

Gaurab Sengupta, Senior Global Business Director, Pharmaceuticals & Nutraceuticals at LLS Health, conveyed what this award means to LLS – Health, saying, “This recognition highlights our commitment to delivering innovative solutions that address critical challenges in the pharmaceutical industry. We’ve zeroed in on a clear unmet need in the solubility enhancement market for critical life-changing drugs. This award demonstrates we are on the right track, validating our efforts to ensure this product is successful.” The Medicine Maker Innovation Awards showcase new drug development and manufacturing technology that has been introduced to the market in 2022. The award signifies LLS Health’s significant contribution to the pharmaceutical industry with its innovative solution. We can expect to learn more about this technology in a future issue of The Medicine Maker.

© 2023 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell a stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.